The merger and reorganization of the pharmaceutical industry step into the fast lane。Successfully set up a new medicine at the Shanghai Government、After the Beijing Municipal Government promotes China Resources Group to hold the northern medicine，There is news，The largest medical distribution company in China，has signed a framework agreement with the Nanjing Municipal Government。Some people in the industry said，Chinese Medicine Holdings will cast mergers and acquisitions into Nanjing Pharmaceutical's parent company South Pharmaceutical Group，Once the cooperation is successful，National Control will reorganize Nanjing Pharmaceutical。 
Message comes out，Public opinion uproar。A person familiar with the matter，National Control Falling Nanjing becomes inevitable，But the object of its reorganization is not Nanjing Medicine。
National Control drops Nanjing
It should be said，The news of the national control reorganization Nanjing Pharmaceutical is not groundless。As a large state -owned enterprise in the pharmaceutical industry，Chinese Medicine Group has always been willing to "play government cards"，Through the establishment of an agreement with the local government，In order to increase local investment in exchange for priority to the market-it passes the framework agreement Stake Sports BettingMy stake betting appwith the Nanjing Government，It is not surprising that it is intended to reorganize Nanjing Pharmaceutical; and the Nanjing Municipal Government's "Cyber ​​Central Enterprise" is also possible，According to relevant industry inspectors，Nanjing Pharmaceutical Group has been an official of Nanjing Municipal Government because many senior officials，"Good at taking care of the overall situation"，But from the current point of view，The two parties do not seem to reach an agreement。
Data display，Nanjing Pharmaceutical's 2009 sales scale 13.5 billion yuan，The company's market network covers Su、Anhui、Fujian、Yu、Lu、Zhejiang、Shanghai and other places，It seems to be an attack available、The princes of the retreat。Industry insiders pointed out，Nanyao Group's assets complex，and Nanjing Medicine is fully capable of developing and growing，State control is more difficult to reorganize in the substantial sense of Nanjing Pharmaceutical Co., Ltd.。
It is reported，At the economic work conference at the beginning of this year of Nanjing Pharmaceutical，The company's senior management "rumor" for the reorganization of national drug desires to reorganize Nanjing Pharmaceutical，Called "Nothing"。A person familiar with the matter tell reporters，At present, the national control has indeed sent someone to audit and evaluate a company in Nanjing，"But the object of the audit evaluation is definitely not Nanjing Medicine"。
Whether it is Nanjing Medicine，Obviously, National Control has chosen to expand forces in Nanjing。Industry insiders pointed out，The biggest advantage of the National Control is the comprehensive distribution network and layout of the national market，Its key areas are in the Bohai Rim、Yangtze River Delta and Pearl River Delta。But as far as the Yangtze River Delta is concerned，National Control Power is still weak,Especially in the face of the strong competitor of the new medicine。
Data display，In the area of ​​East China，New medicine achieved 16 % market share，Location advantage is obvious，East China market accounts for 40 % of the Chinese pharmaceutical consumer market。After the new reorganization Stake Sports Bettingof the medicine，New medicine stake betting appthrough the number of mergers and acquisitions，Greed up its domestic distribution channels; March 25，New medicine signed a comprehensive strategic cooperation framework agreement with Fujian Overseas Chinese Industrial Group，Reorganization Fujian Pharmaceutical Company。So far，The new medicine completed the comprehensive layout of the East China market。
As far as the state control is concerned，Although its management headquarters is located in Shanghai，Previously, there were Shanghai branches，But Shanghai State was withdrawn a few years ago，Sales Division that merged into the state control; although the state control has Suzhou in Jiangsu、Yangzhou two companies，but limited strength。
"Whether it is the State -owned Assets Supervision and Administration Commission's" Five Entry Three "requirements，Still the national medicine must work hard to become the goal of the world's top 500 companies，National control must be merged and reorganized，Realize external expansion。"The person said。The meaning of its words is，State control should strengthen strength in a weak place。In order to strengthen its strength in Jiangsu, Zhejiang and Shanghai，National Control Luozi Nanjing becomes inevitable (more news source E Road has you)。
Analysis of local people in Nanjing，If the state control does not choose Nanjing Pharmaceutical，It is unlikely to choose Jinling Pharmaceutical，Like Nanjing Guosheng、Provincial Industry、Provincial Medicine、Changjiang Pharmaceutical and other medium -sized commercial companies with certain competitiveness may be the object of M & A of the state control。Where，Government Resources、Network Resources、Pharmacy terminal resources、Team management level、Innovation ability is pretty good in Nanjing Guosheng，Become the largest possible。
merger and reorganization accelerates
Data display，More than 13,000 wholesale companies in the country，90%is a small enterprise，Among them, the top 10 market share is only 36 %，and the top three market share of the US pharmaceutical commerce has exceeded 90%。2010，The Ministry of Commerce clearly proposes to increase the concentration stake sports betting appof the industry，Policies stake sports betting appclearly point to large distribution group，Encourage large enterprises to actively merge acquisition。In addition，The basic drug system that is being implemented has also accelerated the integration of pharmaceutical commerce。In the supporting policy of various places，The scale and qualifications of pharmaceutical logistics distribution enterprises are strictly required。Whether there is strength and no government background，It is related to the life and death of pharmaceutical business enterprises。
"Provincial bidding procurement has no effect on the national control department。"Related person pointed out。He said，Business companies acquired by the National Control are generally one of the best companies，plus the national control gold signboard，These companies basically win bids in bidding distribution。Ru Guoshi Holdings Chuangli Co., Ltd. has obtained drug distribution rights in 11 cities in Jiangxi Province; the two companies in Fujian Province in Fujian Province Fujian Pharmaceutical Holding Fujian Co., Ltd. and Guoshu Holdings Fuzhou Co., Ltd. Winning。
Industry insiders pointed out，In the process of merging and reorganization,，Large enterprises will sort，The industrial structure will also change accordingly。He thinks，Follow -up pharmaceutical business will have four patterns: national control、Large enterprises supporting the government supporting the government will accelerate the merger and reorganization; some small and medium -sized business enterprises with certain terminal advantages in the local area, especially the prefecture -level level, will become the object of merger; Holding the group for heating; and those small commercial companies that cannot get the right of delivery but have a good connection at the hospital terminal，can help large companies do terminal promotion。
In recent years，The first three times in Chinese pharmaceutical commerce are basically maintained as Chinese medicine holding、Shanghai Pharmaceutical Co., Ltd. and Kyushu Tong Group Co., Ltd.。Data show，In 2009, the sales of national medicine holding reached 44.6 billion yuan; the stake online sports bettingintegrated "new medicine" was expected to reach My stake betting app30 billion yuan; Kyushu Tong achieved sales of 22 billion yuan。In 2008 ranking，Nanjing Medicine、Guangzhou Medicine、Beijing Medicine、Chongqing Pharmaceutical Co., Ltd. is ranked among the top ten。
It is not difficult to see，In the pharmaceutical business giant series，Kyushu Tong, a private origin, is in front of it、In the dilemma of chasing troops later。Well -known，Kyushu Tong started with a fast batch，Its terminal customers are mostly small wholesalers、Retail pharmacy and grass -roots medical institutions，has not yet established a solid relationship with large medical institutions;，It also determines that it is difficult to hold hands with relevant government departments。An industry person pointed out，Kyushu Tong currently focus on breaking two points，First, build modern medicine logistics，Second is to speed up the construction of the hospital terminal。It is reported，Kyushu Tong has established a hospital development department at the end of last year，Start the channel to enter the hospital。
What can be imagined is，With this round of merger and reorganization,，In the future, the pattern of my country's pharmaceutical business will change，Leader ranking may be rewritten。